GSK plc
GSK
#226
Rank
NZ$170.03 B
Marketcap
NZ$84.80
Share price
1.47%
Change (1 day)
27.71%
Change (1 year)

Market capitalization of GSK plc (GSK)

Market cap: NZ$170.03 Billion

As of June 2026 GSK plc has a market cap of NZ$170.03 Billion. This makes GSK plc the world's 226th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of GSK plc from 1996 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$170.03 B-0.86%
2025NZ$171.51 B39.11%
2024NZ$123.29 B2.25%
2023NZ$120.57 B6.42%
2022NZ$113.30 B-29.07%
2021NZ$159.73 B25.6%
2020NZ$127.17 B-26.41%
2019NZ$172.81 B23.4%
2018NZ$140.04 B12.87%
2017NZ$124.07 B-8.78%
2016NZ$136.02 B-6.02%
2015NZ$144.73 B8.86%
2014NZ$132.94 B-15.31%
2013NZ$156.99 B22.1%
2012NZ$128.57 B-12.89%
2011NZ$147.59 B11.75%
2010NZ$132.08 B-12.52%
2009NZ$150.97 B-9.36%
2008NZ$166.56 B-8.07%
2007NZ$181.18 B-15.93%
2006NZ$215.52 B-0.04%
2005NZ$215.60 B9.35%
2004NZ$197.17 B-2.67%
2003NZ$202.58 B-6.04%
2002NZ$215.60 B-41.78%
2001NZ$370.30 B-6.85%
2000NZ$397.52 B104.24%
1999NZ$194.63 B-18.59%
1998NZ$239.07 B62.13%
1997NZ$147.46 B85.1%
1996NZ$79.66 B

End of Day market cap according to different sources

On Jun 3rd, 2026 the market cap of GSK plc was reported to be:

NZ$172.97 Billion
by Nasdaq info icon info icon
NZ$170.03 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Novartis
NVS
NZ$467.50 B 174.94%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$246.31 B 44.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$172.97 B 1.73%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
NZ$483.14 B 184.14%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$466.25 B 174.21%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
NZ$65.19 B-61.66%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Dynavax Technologies
DVAX
NZ$3.10 B-98.17%๐Ÿ‡บ๐Ÿ‡ธ USA